Home › RetroSense Therapeutics' Lead Gene Therapy Candidate Gets FDA Clearance To Proceed To First-In-Human Clinical Trials
 

Keywords :   


RetroSense Therapeutics' Lead Gene Therapy Candidate Gets FDA Clearance To Proceed To First-In-Human Clinical Trials

2015-09-02 07:40:59| drugdiscoveryonline News Articles

RetroSense Therapeutics LLC, a privately-held biopharmaceutical company, recently announced the Company’s Investigational New Drug (IND) application for RST-001 received clearance from the United States Food and Drug Administration (FDA)

Tags: lead clinical therapy candidate

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Unpaid carers being forced to repay 250m to DWP
18.05Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
More »